Huntington's disease (HD) is due to a dominant gene of high penetrancy, yet the presence or absence of this abnormal gene can not usually be ascertained until obvious physical signs appear in the affected individual. Numerous predictive tests have been developed, but at present none is definitely reliable.' 2 Oral levodopa increases chorea in affected patients through altered striatal response to dopamine.3 There are no data to show at which age this abnormal susceptibility develops but Klawans et a14 5 reported that onethird of presymptomatic HD descendants developed transient facial or limb dyskinesias or both after receiving oral levodopa and assumed that they would later develop the disease. Mainly because of uncertainty as to how to interpret these results, these investigators now rarely, if ever, use this test. 2 Various parameters of the late response (R2) of the electrically evoked blink reflex are abnormal in HD6-8 and previous data suggested that once changes can be demonstrated even in early in-cipient cases. Levodopa is known to modify this reflex; its pattern in Parkinson's disease is reversed by treatment. 9 10 It appeared that in presymptomatic subjects at risk of HD submitted to a levodopa predictive test, the simultaneous examination of the blink reflex possibly would provide a more sensitive and quantifiable method of detection than the simple visual search for choreic movements.
In this study, 17 figure) . Furthermore, each of these seven cases had a habituation index value below the mean in control subjects (071).
None of the three parameters evaluated differed from normal controls, before or after levodopa in the other 10 descendants. The two individuals (cases 2 and 14, table 3) in which the presence of levodopa-induced dyskinesias was questioned clinically, experienced no changes in their blink reflex patterns. The mean age of HD descendants having an abnormal blink reflex (28-4 years) was similar to those having normal values (29-3 years). A nine year old girl, who was the youngest subject examined from group B, had also the more severe degree of abnormal blink reflex. The onset of HD in her mother was at 23 years and several other affected members from her family, including case 3 of group C, also had an unusually early onset of the disease.
Mean latency and habituation index values from these four cases of incipient HD (group C) differed from normal controls (p<0-001 and p<0-05, respectively), both before and after the acute levodopa provocative test (table 2) . Basal individual latency values also were greater than the maximum normal value (36-7 ms) from the control group (table 4; figure) . A further shift towards abnormality was obtained after the acute administration of levodopa and, in addition, the differential latency also became abnormal in two cases, in parallel with a levodopa-induced deterioration of the choreic movements. The patient in whom there was no appreciable increase of the choreic movements on levodopa (case 2, table 4) also was the only one in which the blink reflex pattern remained unmodified.
Discussion
The incipient HD group consisted of four fully employed individuals, unaware of their illness which was detected during routine family surveys. Nevertheless, it was obvious to the experienced neurologist that they had mild yet characteristic choreic movements. This group had a R2 response of their blink reflex modified in a Negative values of DL means that R2 response contralateral to the stimulated side appears earlier than the ipsilateral one.
Figure Mean values ± 2 SD of latency and differential latency of the R2 response of the blink reflex on both sides from a sample of 20 healthy subjects are represented within the dotted line (rectangle). induced a clearcut increase in the severity of chorea in individuals who had already mild abnormal involuntary movements before any treatment with levodopa (as in our incipient group C).
We plan to retest and publish the results after a five year period of observation of the HD descendants. Either an increase in the electrophysiological abnormalities already detected in still clinically unaffected subjects, or the emergence of the disease during that time may occur, but it may take much longer to decide whether the test does give reliable predictive information. We would encourage other groups to undertake the present investigation and to check its reproductibility in individuals at risk demanding a predictive test. Not only does it provide objective quantifiable abnormalities, but it avoids the unwanted situation of prematurely facing the subject with the image of his eventual illness by inducing chorea. 
